Department of Gastroenterology, Veterans Affairs Medical Center, Kansas City, Missouri, United States.
Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States.
Endoscopy. 2020 Sep;52(9):721-726. doi: 10.1055/a-1172-5975. Epub 2020 May 25.
Post-esophagectomy anastomotic strictures are difficult to treat. The impact of adding local steroid injection to endoscopic dilation for the treatment of post-esophagectomy anastomotic strictures is unclear. We conducted a systematic review and meta-analysis to assess the efficacy of performing steroid injection in addition to dilation.
A search was conducted in MEDLINE, Cochrane Library, EMBASE, and Web of Science from inception to January 2019. Randomized controlled trials (RCTs) comparing the efficacy of endoscopic dilation plus either local steroid injection (steroid group) or saline injection (placebo group) were included in the analysis.
Three RCTs were eligible for the final analysis: 72 patients (mean age 61.3 years, 74 % male) in the steroid group and 72 patients (mean age 59.6 years, 71 % male) in the placebo group. The mean number of dilations required to resolve the stricture was significantly lower in the steroid group compared with the placebo group, with a mean weighted difference of -1.62 (95 % confidence interval [CI] -2.73 to -0.50; = 0.004). After 6 months of follow-up, there was a trend toward more patients in the steroid group remaining dysphagia free compared with the placebo group, with a pooled odds ratio of 2.36 (95 %CI 0.94 to 5.91; = 0.07, = 24 %).
This meta-analysis showed that the addition of local steroid injection at the time of dilation for benign anastomotic strictures led to a significant decrease in the number of procedures required to resolve the stricture and may well reduce dysphagia symptoms during follow-up.
食管切除术后吻合口狭窄较难治疗。在食管切除术后吻合口狭窄的内镜扩张治疗中添加局部皮质类固醇注射的效果尚不清楚。我们进行了系统评价和荟萃分析,以评估在扩张治疗的基础上进行皮质类固醇注射的疗效。
从建库至 2019 年 1 月,我们在 MEDLINE、Cochrane 图书馆、EMBASE 和 Web of Science 中进行了检索。我们分析了比较内镜扩张加局部皮质类固醇注射(皮质类固醇组)或生理盐水注射(安慰剂组)疗效的随机对照试验(RCT)。
有 3 项 RCT 符合最终分析的纳入标准:皮质类固醇组 72 例患者(平均年龄 61.3 岁,74%为男性),安慰剂组 72 例患者(平均年龄 59.6 岁,71%为男性)。与安慰剂组相比,皮质类固醇组需要进行的扩张操作数量明显减少,平均加权差异为-1.62(95%置信区间-2.73 至-0.50; = 0.004)。在 6 个月的随访后,皮质类固醇组有更多的患者保持无吞咽困难,合并优势比为 2.36(95%置信区间 0.94 至 5.91; = 0.07, = 24 %)。
本荟萃分析显示,在良性吻合口狭窄的内镜扩张治疗中添加局部皮质类固醇注射可显著减少缓解狭窄所需的操作次数,并可能在随访期间减轻吞咽困难症状。